Literature DB >> 6303751

Analysis of growth hormone and lactogenic binding sites cross-linked to iodinated human growth hormone.

J P Hughes, J S Simpson, H G Friesen.   

Abstract

GH (GHR) and lactogenic receptors were analyzed after use of the cross-linking reagent ethylene glycol bis-(succinimidyl succinate) to attach covalently iodinated human GH (hGH) to binding proteins 1) on intact IM-9 lymphocytes, 2) in a partially purified GHR preparation from rabbit liver, and 3) in crude microsomal fractions from rabbit liver, rabbit mammary gland, and rat liver. The latter two microsomal preparations contain primarily lactogenic receptors, whereas in IM-9 lymphocytes and the rabbit liver preparations, GHR predominate. Cross-linked [125I]hGH-receptor complexes were solubilized, reduced, and separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analysis of proteins cross-linked to [125I]hGH in the microsomal fraction from rabbit liver showed a specifically labeled complex with an estimated molecular weight (mol wt) of 75K. A slightly lower mol wt (71K) was determined for the complex labeled in the purified GHR preparation. In contrast to the relatively low mol wt complexes in rabbit liver, a complex that migrated with an apparent mol wt of 130K was identified in IM-9 lymphocytes. Labeled complexes were identified at 66K from rat liver and 61K from rabbit mammary gland. If it is assumed that hGH contributes 21K to the mol wt of the radiolabeled complexes, then the approximate mol wts of hGH-binding sites are 50-54K from rabbit liver, 109K from IM-9 lymphocytes, 45K from rat liver, and 40K from rabbit mammary gland.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303751     DOI: 10.1210/endo-112-6-1980

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  The human growth hormone receptor of cultured human lymphocytes. Structural characteristics and glycosylation properties.

Authors:  K Asakawa; J A Hedo; A McElduff; D G Rouiller; M J Waters; P Gorden
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

2.  Heterogeneity of growth-hormone receptors detected with monoclonal antibodies to human growth hormone.

Authors:  H Thomas; I C Green; M Wallis; R Aston
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

3.  The specificity of binding of growth hormone and prolactin to purified plasma membranes from pregnant-rabbit liver.

Authors:  C F Webb; H F Cadman; M Wallis
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

4.  A comparison of lactogenic receptors from rat liver and Nb2 rat lymphoma cells by using cross-linking techniques.

Authors:  C F Webb; M Wallis
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

5.  Structural studies on membrane-bound and soluble growth-hormone-binding proteins of rabbit liver.

Authors:  S I Ymer; A C Herington
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

6.  Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

Authors:  W H Daughaday; B Trivedi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Characterization of prolactin receptors in pig mammary gland.

Authors:  S Sakai; M Katoh; P Berthon; P A Kelly
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

8.  Lactogenic and somatogenic binding sites in intact and detergent-solubilized membrane preparations of female rat liver.

Authors:  L A Haldosén; J A Gustafsson
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

Review 9.  Growth hormone signal transduction.

Authors:  P Maharajan; V Maharajan
Journal:  Experientia       Date:  1993-11-15

10.  Separation of rabbit mammary-gland prolactin receptors by ion-exchange chromatography, h.p.l.c.-gel filtration and ultracentrifugation.

Authors:  S Sakai; F Ike; K Kohmoto; T Johke
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.